Ken Warrington
Direktor/Vorstandsmitglied bei BIOSTEM TECHNOLOGIES INC
Vermögen: - $ am 31.05.2024
Aktive Positionen von Ken Warrington
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| BIOSTEM TECHNOLOGIES INC | Direktor/Vorstandsmitglied | 01.03.2022 | - |
| Corporate Officer/Principal | 29.10.2019 | 01.03.2022 |
Karriereverlauf von Ken Warrington
Ehemalige bekannte Positionen von Ken Warrington
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| GENSCRIPT PROBIO USA INC. | Corporate Officer/Principal | 01.01.2020 | 01.12.2021 |
| Biostem Life Sciences, Inc. | Geschäftsführer | 01.06.2019 | 01.05.2020 |
Lacerta Therapeutics, Inc.
 Lacerta Therapeutics, Inc. BiotechnologyHealth Technology Lacerta Therapeutics, Inc. operates as a a clinical stage gene therapy company. The firm engages in development, production, and application of AAV vectors. The company was founded by Nicholas Muzyczka, Barry Byrne, Arun Srivastava, Coy Heldermon, Sergei Zolothukin, Kenneth Warrington, Ronald Mandel, Toadd E. Golde and Edgardo Rodriguez in 2017 and is headquartered in Alachua, FL. | Technik-/Wissenschafts-/F&E-Leiter | 01.11.2017 | 01.05.2019 |
Ausbildung von Ken Warrington
| University of Florida | Doctorate Degree |
| The St. Lawrence College | Undergraduate Degree |
Statistik
International
| Vereinigte Staaten | 6 |
| Vereinigtes Königreich | 2 |
Operativ
| Corporate Officer/Principal | 2 |
| Director/Board Member | 1 |
| Chief Operating Officer | 1 |
Sektoral
| Consumer Services | 3 |
| Health Technology | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| BIOSTEM TECHNOLOGIES INC | Health Technology |
| Private Unternehmen | 3 |
|---|---|
Lacerta Therapeutics, Inc.
Lacerta Therapeutics, Inc. BiotechnologyHealth Technology Lacerta Therapeutics, Inc. operates as a a clinical stage gene therapy company. The firm engages in development, production, and application of AAV vectors. The company was founded by Nicholas Muzyczka, Barry Byrne, Arun Srivastava, Coy Heldermon, Sergei Zolothukin, Kenneth Warrington, Ronald Mandel, Toadd E. Golde and Edgardo Rodriguez in 2017 and is headquartered in Alachua, FL. | Health Technology |
| GENSCRIPT PROBIO USA INC. | |
| Biostem Life Sciences, Inc. |
- Börse
- Insiders
- Ken Warrington
- Erfahrung
